Autoimmune Presentation Rhupus Like of lung cancer non-small cells

Authors

DOI:

https://doi.org/10.52076/eacad-v3i2.168

Keywords:

Rheumatoid Arthritis; Lupus; Autoimmunity.

Abstract

Introduction: Rhupus, or Rhupus Syndrome, is a rare rheumatologic disease characterized by the overlapping of Systemic Lupus Erythematosus and Rheumatoid Arthritis in patients meeting SLICC and ACR/EULAR criteria. Objective: To describe the clinical case of a patient with non-small cell lung cancer presenting with Rhupus Syndrome and to review the literature on Rhupus and its clinical features. Methodology: Case report type of study descriptive qualitative with information obtained directly from the medical records kept during hospitalization. Discussion: Rhupus Syndrome, characterized by the overlapping of SLE and RA, has two most common presentations, the first are patients who begin with RA, and then are diagnosed with SLE, comprising 2/3 of the cases of Rhupus. The second presentation consists of patients initially with SLE or with both diseases diagnosed at the beginning. As this is a rare syndrome, there are no validated diagnostic criteria for this disease. Conclusion: Although the interposition of rheumatologic diseases is not rare, Rhupus has an estimated prevalence of 0.09% of the population. Diagnosis may be difficult because there are no well-defined diagnostic criteria and because of its rarity; however, this diagnosis may be determinant for an adequate approach to the patient and a better prognosis, reducing complications related to SLE and/or RA.

References

ANTONIHGNI, Luca, et al. Rhupus: a systematic literature review. Autoimmunity Reviews, p. 102-612, 2020.

AZMECUA-GUERRA, LM. Overlap between systemic lupus erythematosus and rheumatoid arthritis: is it real or just an illusion?. J. Rheumatol; 36:4-6, 2009.

BRITO, Tayra H G; et al. Relato de Caso–Síndrome de RUPHUS: uma excepcionalidade diagnostica. Brazilian Journal of Health Review, v. 4, n. 2, p. 6714-6719, 2021.

DANION, François et al. Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients. Rheumatic and Musculoskeletal Diseases, v. 3, n. 2, p. e000555, 2017.

LI, Jing et al. Clinical analysis of 56 patients with rhupus syndrome: manifestations and comparisons with systemic lupus erythematosus: a retrospective case–control study. Medicine (Baltimore), v. 93, n. 10, 2014.

LIU, T et al. Clinical and laboratory profiles of rhupus syndrome in a Chinese population: a single-centre study of 51 patients. Lupus; 23:958-63, 2014.

SIMON, T.A, et al. Prevalence of co- existing autoimmune disease in rheumatoid arthritis: a cross-sectional study. Adv Ther; 34:2481–90, 2017.

SOLIS CARTAS, Urbano et al. Rhupus syndrome. A rare combination. Revista Colombiana de Reumatología, v. 24, n. 4, p. 237-241, 2017.

WALLACE, Daniel J. et al. Dubois’ lupus erythematosus and related syndromes. 8th edition. Pg 543-544, 2013.

ZIEGELASCH M, et al. Antibodies against carbamylated proteins and cyclic citrullinated pep- tides in systemic lupus erythematosus: results from two well-defined-European cohorts. Arthritis Res Ther; 18:289, 2016.

Published

16/06/2022

How to Cite

Barbosa Filho, R. ., Menezes, T. B. M. de ., Dias, P. R. de S. ., Silva, E. T. M. F. ., Lustosa, K. ., & Costa, F. A. M. da . (2022). Autoimmune Presentation Rhupus Like of lung cancer non-small cells. E-Acadêmica, 3(2), e4432168. https://doi.org/10.52076/eacad-v3i2.168

Issue

Section

Health and Biological Sciences